Skip to main content
. 2019 Apr 22;10(5):816–821. doi: 10.1021/acsmedchemlett.9b00091

Figure 5.

Figure 5

CMT-3. (A) Structure of CMT-3 in comparison to the tetracycline scaffold. (B) Plot of dose-dependent inhibition by CMT-3. (C) Table of binding affinities and inhibition constants (NB = no binding). The IC50 values are represented as 95% confidence intervals.